Centro de Investigação Farmacológica e Inovação Medicamentosa

Homepage: medinup.pt

Alternate names: Center for Drug Discovery and Innovative Medicines, Universidade do Porto Centro de Investigação Farmacológica e Inovação Medicamentosa

Parent institution: Universidade do Porto

ROR: 02dtdp942

OpenAlex ID: I4405254940

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2017 · Fernando Magro, Paolo Gionchetti, et al. · Journal of Crohn s and Colitis · 1,978

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

2016 · Paolo Gionchetti, Axel Dignass, et al. · Journal of Crohn s and Colitis · 794

PDF

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

2014 · C.J. van der Woude, S. Ardizzone, et al. · Journal of Crohn s and Colitis · 483

PDF

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

2015 · Joaquim J Ferreira, Andrew Lees, et al. · The Lancet Neurology · 304

α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B

2017 · Diana G Ferreira, Mariana Temido-Ferreira, et al. · Nature Neuroscience · 288

2018 · Mariana Temido-Ferreira, Diana G. Ferreira, et al. · Molecular Psychiatry · 194

PDF

Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets

2021 · Marta Reina-Couto, Patrícia Pereira-Terra, et al. · Frontiers in Physiology · 164

PDF

Oxidative Stress and DNA Damage

2015 · Cristiana Pereira, Daniela Grácio, et al. · Inflammatory Bowel Diseases · 161

Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease

2020 · Mafalda R. Couto, Pedro Gonçalves, et al. · Pharmacological Research · 153

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide

2014 · Simon Hebeisen, Nuno Pires, et al. · Neuropharmacology · 134

Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels

2018 · Fernando Magro, Joanne Lopes, et al. · Gut · 116

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III , double‐blind, randomized, placebo‐controlled trial

2014 · Michael R. Sperling, Bassel Abou‐Khalil, et al. · Epilepsia · 114

PDF

Neuroinflammation, oxidative stress and their interplay in neuropathic pain: Focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies

2020 · Luísa Teixeira-Santos, António Albino-Teixeira, et al. · Pharmacological Research · 108

Metabolic Inflammation in Inflammatory Bowel Disease

2014 · Pedro Gonçalves, Fernando Magro, et al. · Inflammatory Bowel Diseases · 108

Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility

2014 · László E. Kiss, Patrício Soares-da-Silva · Journal of Medicinal Chemistry · 104

2015 · Cristina Silva, Célia Ramalho, et al. · International Journal of Clinical Pharmacy · 101

Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies

2014 · C. C. Dias, P. P. Rodrigues, et al. · Journal of Crohn s and Colitis · 100

Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure

2019 · Thomas Chateau, Roger Feakins, et al. · The American Journal of Gastroenterology · 95

Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity

2015 · Diana G. Ferreira, Vânia L. Batalha, et al. · Cerebral Cortex · 95

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug

2014 · Anna Doeser, Gesa Dickhof, et al. · Brain · 89

Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study

2018 · Eugen Trinka, Elinor Ben‐Menachem, et al. · Epilepsia · 86

PDF

Nocardia infections among immunomodulated inflammatory bowel disease patients: A review

2015 · Cândida Abreu · World Journal of Gastroenterology · 70

PDF

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

2020 · the OPTIPARK investigators, Heinz Reichmann, et al. · Translational Neurodegeneration · 69

PDF

DNA Damage and Oxidative DNA Damage in Inflammatory Bowel Disease

2016 · Cristiana Pereira, Rosa Coelho, et al. · Journal of Crohn s and Colitis · 69

PDF

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

2014 · José-Francisco Rocha, Amílcar Falcão, et al. · European Journal of Clinical Pharmacology · 68

Works count: 424

Citation count: 22,250